{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:49:46Z","timestamp":1768924186593,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aed.2025.08.016","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:52:21Z","timestamp":1756947141000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aldosterone Levels Post-IV Saline Suppression Using Commercial Reference Laboratory Liquid Chromatography-Tandem Mass Spectrometry Assay"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-4729","authenticated-orcid":false,"given":"Stanley M.","family":"Chen Cardenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7135-8893","authenticated-orcid":false,"given":"Vidhu","family":"Vadini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5130-0060","authenticated-orcid":false,"given":"Lori","family":"Sokoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9307-1315","authenticated-orcid":false,"given":"Mohammed S.","family":"Abusamaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2244","authenticated-orcid":false,"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-1472","authenticated-orcid":false,"given":"Seyedeh Yasaman","family":"Alemohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-6983","authenticated-orcid":false,"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9693-7433","authenticated-orcid":false,"given":"Aarti","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-8687","authenticated-orcid":false,"given":"Lilah F.","family":"Morris-Wiseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-9385","authenticated-orcid":false,"given":"Amir H.","family":"Hamrahian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aed.2025.08.016_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coemr.2019.07.001","article-title":"The prevalence of primary aldosteronism and evolving approaches for treatment","volume":"8","author":"Yozamp","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"7","key":"10.1016\/j.aed.2025.08.016_bib2","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Archive Intern Med"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12020-022-03168-8","article-title":"Secondary diabetes mellitus due to primary aldosteronism","volume":"79","author":"Moustaki","year":"2023","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.aed.2025.08.016_bib6","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.aed.2025.08.016_bib7","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4158\/EP-2020-0277","article-title":"Mineralocorticoid receptor antagonists decrease the rates of positive screening for primary aldosteronism","volume":"26","author":"Tezuka","year":"2020","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.aed.2025.08.016_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan endocrine society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.aed.2025.08.016_bib9","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test -Variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.aed.2025.08.016_bib10","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.aed.2025.08.016_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.aed.2025.08.016_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1530\/EJE-20-0030","article-title":"Prospective evaluation of aldosterone LC-MS\/MS-specific cutoffs for the saline infusion test","volume":"183","author":"Fries","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.aed.2025.08.016_bib13","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1373\/clinchem.2010.146449","article-title":"Plasma renin activity by LC-MS\/MS: Development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity","volume":"56","author":"Bystrom","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.aed.2025.08.016_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.124.22884","article-title":"Comparing ARR versus suppressed PRA as screening tests for primary aldosteronism","author":"Marcelli","year":"2024","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM196707062770101","article-title":"Effect of saline infusions on aldosterone secretion and electrolyte excretion in normal subjects and patients with primary aldosteronism","volume":"277","author":"Espiner","year":"1967","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.aed.2025.08.016_bib16","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1172\/JCI103386","article-title":"The regulation of aldosterone secretion in man: the role of fluid volume","volume":"35","author":"Barber","year":"1956","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.aed.2025.08.016_bib17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.1971.00310210056004","article-title":"Saline suppression of plasma aldosterone in hypertension","volume":"128","author":"David Kem","year":"1971","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.aed.2025.08.016_bib18","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac049","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography-tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endocr Soc"},{"issue":"5","key":"10.1016\/j.aed.2025.08.016_bib19","doi-asserted-by":"crossref","first-page":"E2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajh\/hpaa151","article-title":"Variability of aldosterone measurements during adrenal venous sampling for primary aldosteronism","volume":"34","author":"Yozamp","year":"2021","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.aed.2025.08.016_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/HYPERTENSIONAHA.123.21983","article-title":"Long-term Follow-Up of patients with elevated aldosterone-to-renin ratio but negative confirmatory test: the progression of primary aldosteronism phenotypes","volume":"81","author":"Buffolo","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.aed.2025.08.016_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchromb.2014.08.042","article-title":"Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS\/MS and comparison with commercial immunoassays","volume":"970","author":"Ray","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.aed.2025.08.016_bib24","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/HJH.0000000000001735","article-title":"Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration","volume":"36","author":"Baron","year":"2018","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.aed.2025.08.016_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis","volume":"48","author":"Rehan","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.aed.2025.08.016_bib26","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae145","article-title":"The spectrum of dysregulated aldosterone production: an international human physiology study","author":"Parksook","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.aed.2025.08.016_bib27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.aed.2025.08.016_bib29","first-page":"28","article-title":"Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism","volume":"80","author":"Siragy","year":"1995","journal-title":"J Clin Endocrinol Metahohsm C"},{"issue":"5","key":"10.1016\/j.aed.2025.08.016_bib30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual variability of Serum aldosterone and implications for primary aldosteronism screening","volume":"108","author":"Maciel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.aed.2025.08.016_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.aed.2025.08.016_bib32","doi-asserted-by":"crossref","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism","author":"Leung","year":"2025","journal-title":"Ann Intern Med"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915725001067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:29:36Z","timestamp":1768868976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915725001067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S3050915725001067"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2025.08.016","relation":{},"ISSN":["3050-9157"],"issn-type":[{"value":"3050-9157","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone Levels Post-IV Saline Suppression Using Commercial Reference Laboratory Liquid Chromatography-Tandem Mass Spectrometry Assay","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2025.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Clinical Endocrinology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}